Arbutus Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	191.45	14.08	6.17	18.14	39.02	10.99
Revenue Growth (YoY)	2889.93%	128.21%	-65.98%	-53.51%	255.11%	58.92%
Gross Profit	191.45	14.08	6.17	18.14	39.02	10.99
Selling, General & Admin	15.95	15.89	22.11	22.48	17.83	17.14
Research & Development	20.4	25.24	54.04	73.7	84.41	65.5
Other Operating Expenses	-1.35	11.11	6.35	0.07	2.23	1.87
Total Operating Expenses	35	52.24	82.49	96.24	104.48	84.51
Operating Income	156.45	-38.16	-76.32	-78.1	-65.46	-73.52
Interest Income	3.69	4.07	6.59	5.69	2.19	0.13
Interest Expense	-0.09	-0.1	-0.14	-0.46	-1.73	-2.86
Other Non-Operating Income (Expense)	-0	0.69	-0.05	0.03	-0.02	0.01
Total Non-Operating Income (Expense)	4.27	4.66	6.4	5.25	0.44	-2.73
Pretax Income	160.72	-33.5	-69.92	-72.85	-65.01	-76.25
Provision for Income Taxes	-	-	-	-	-4.44	-
Net Income	160.72	-33.5	-69.92	-72.85	-69.46	-76.25
Net Income to Common	160.72	-33.5	-69.92	-72.85	-69.46	-88.39
Shares Outstanding (Basic)	192	192	186	166	151	106
Shares Outstanding (Diluted)	193	192	186	166	151	106
Shares Change (YoY)	1.89%	3.23%	11.84%	9.95%	42.07%	40.10%
EPS (Basic)	0.84	-0.17	-0.38	-0.44	-0.46	-0.83
EPS (Diluted)	0.83	-0.17	-0.38	-0.44	-0.46	-0.83
Free Cash Flow	-34.36	-39.64	-65.03	-86.94	-35.87	-68.34
Free Cash Flow Per Share	-0.18	-0.21	-0.35	-0.52	-0.24	-0.64
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	81.72%	-270.96%	-1236.74%	-430.53%	-167.75%	-669.11%
Profit Margin	83.95%	-237.88%	-1133.04%	-401.57%	-178.01%	-693.91%
FCF Margin	-17.95%	-281.45%	-1053.83%	-479.27%	-91.92%	-621.96%
EBITDA	156.49	-37.8	-74.94	-76.7	-64.03	-71.77
EBITDA Margin	81.74%	-268.39%	-1214.37%	-422.79%	-164.10%	-653.16%
EBIT	156.45	-38.16	-76.32	-78.1	-65.46	-73.52
EBIT Margin	81.72%	-270.96%	-1236.74%	-430.53%	-167.75%	-669.11%
Effective Tax Rate	-	0.00%	0.00%	0.00%	6.84%	0.00%

SEC Filings: 10-K · 10-Q